Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Recruiting

Phase 1

BNT317Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Sponsor:

BioNTech SE

Code:

NCT06750185

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BNT317 DL1

BNT317 DL2

BNT317 DL3

BNT317 DL4

BNT317 DL5 (intermediate)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-25. This information was provided to ClinicalTrials.gov by BioNTech SE on 2025-05-31.